Reactive oxygen species cause endothelial dysfunction in chronic flow overload

X. Lu, X. Guo, C. D. Wassall, M. D. Kemple, J. L. Unthank, G. S. Kassab

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Although elevation of shear stress increases production of vascular reactive oxygen species (ROS), the role of ROS in chronic flow overload (CFO) has not been well investigated. We hypothesize that CFO increases ROS production mediated in part by NADPH oxidase, which leads to endothelial dysfunction. In six swine, CFO in carotid arteries was induced by contralateral ligation for 1 wk. In an additional group, six swine received apocynin (NADPH oxidase blocker and anti-oxidant) treatment in conjunction with CFO for 1 wk. The blood flow in carotid arteries increased from 189.2 ± 25.3 ml/min (control) to 369.6 ± 61.9 ml/min (CFO), and the arterial diameter increased by 8.6%. The expressions of endothelial nitric oxide synthase (eNOS), p22/p47phox, and NOX2/NOX4 were upregulated. ROS production increased threefold in response to CFO. The endothelium-dependent vasorelaxation was compromised in the CFO group. Treatment with apocynin significantly reduced ROS production in the vessel wall, preserved endothelial function, and inhibited expressions of p22/p47phox and NOX2/NOX4. Although the process of CFO remodeling to restore the wall shear stress has been thought of as a physiological response, the present data implicate NADPH oxidase-produced ROS and eNOS uncoupling in endothelial dysfunction at 1 wk of CFO.

Original languageEnglish
Pages (from-to)520-527
Number of pages8
JournalJournal of Applied Physiology
Volume110
Issue number2
DOIs
StatePublished - Feb 2011

Fingerprint

Reactive Oxygen Species
NADPH Oxidase
Nitric Oxide Synthase Type III
Carotid Arteries
Swine
Oxidants
Vasodilation
Endothelium
Ligation
Blood Vessels
acetovanillone

Keywords

  • Chronic flow overload
  • Endothelial dysfunction
  • NADPH oxidase
  • Reactive oxygen species

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Lu, X., Guo, X., Wassall, C. D., Kemple, M. D., Unthank, J. L., & Kassab, G. S. (2011). Reactive oxygen species cause endothelial dysfunction in chronic flow overload. Journal of Applied Physiology, 110(2), 520-527. https://doi.org/10.1152/japplphysiol.00786.2009

Reactive oxygen species cause endothelial dysfunction in chronic flow overload. / Lu, X.; Guo, X.; Wassall, C. D.; Kemple, M. D.; Unthank, J. L.; Kassab, G. S.

In: Journal of Applied Physiology, Vol. 110, No. 2, 02.2011, p. 520-527.

Research output: Contribution to journalArticle

Lu, X, Guo, X, Wassall, CD, Kemple, MD, Unthank, JL & Kassab, GS 2011, 'Reactive oxygen species cause endothelial dysfunction in chronic flow overload', Journal of Applied Physiology, vol. 110, no. 2, pp. 520-527. https://doi.org/10.1152/japplphysiol.00786.2009
Lu, X. ; Guo, X. ; Wassall, C. D. ; Kemple, M. D. ; Unthank, J. L. ; Kassab, G. S. / Reactive oxygen species cause endothelial dysfunction in chronic flow overload. In: Journal of Applied Physiology. 2011 ; Vol. 110, No. 2. pp. 520-527.
@article{1ec2265abf164b74bcb05312700a865c,
title = "Reactive oxygen species cause endothelial dysfunction in chronic flow overload",
abstract = "Although elevation of shear stress increases production of vascular reactive oxygen species (ROS), the role of ROS in chronic flow overload (CFO) has not been well investigated. We hypothesize that CFO increases ROS production mediated in part by NADPH oxidase, which leads to endothelial dysfunction. In six swine, CFO in carotid arteries was induced by contralateral ligation for 1 wk. In an additional group, six swine received apocynin (NADPH oxidase blocker and anti-oxidant) treatment in conjunction with CFO for 1 wk. The blood flow in carotid arteries increased from 189.2 ± 25.3 ml/min (control) to 369.6 ± 61.9 ml/min (CFO), and the arterial diameter increased by 8.6{\%}. The expressions of endothelial nitric oxide synthase (eNOS), p22/p47phox, and NOX2/NOX4 were upregulated. ROS production increased threefold in response to CFO. The endothelium-dependent vasorelaxation was compromised in the CFO group. Treatment with apocynin significantly reduced ROS production in the vessel wall, preserved endothelial function, and inhibited expressions of p22/p47phox and NOX2/NOX4. Although the process of CFO remodeling to restore the wall shear stress has been thought of as a physiological response, the present data implicate NADPH oxidase-produced ROS and eNOS uncoupling in endothelial dysfunction at 1 wk of CFO.",
keywords = "Chronic flow overload, Endothelial dysfunction, NADPH oxidase, Reactive oxygen species",
author = "X. Lu and X. Guo and Wassall, {C. D.} and Kemple, {M. D.} and Unthank, {J. L.} and Kassab, {G. S.}",
year = "2011",
month = "2",
doi = "10.1152/japplphysiol.00786.2009",
language = "English",
volume = "110",
pages = "520--527",
journal = "Journal of Applied Physiology",
issn = "8750-7587",
publisher = "American Physiological Society",
number = "2",

}

TY - JOUR

T1 - Reactive oxygen species cause endothelial dysfunction in chronic flow overload

AU - Lu, X.

AU - Guo, X.

AU - Wassall, C. D.

AU - Kemple, M. D.

AU - Unthank, J. L.

AU - Kassab, G. S.

PY - 2011/2

Y1 - 2011/2

N2 - Although elevation of shear stress increases production of vascular reactive oxygen species (ROS), the role of ROS in chronic flow overload (CFO) has not been well investigated. We hypothesize that CFO increases ROS production mediated in part by NADPH oxidase, which leads to endothelial dysfunction. In six swine, CFO in carotid arteries was induced by contralateral ligation for 1 wk. In an additional group, six swine received apocynin (NADPH oxidase blocker and anti-oxidant) treatment in conjunction with CFO for 1 wk. The blood flow in carotid arteries increased from 189.2 ± 25.3 ml/min (control) to 369.6 ± 61.9 ml/min (CFO), and the arterial diameter increased by 8.6%. The expressions of endothelial nitric oxide synthase (eNOS), p22/p47phox, and NOX2/NOX4 were upregulated. ROS production increased threefold in response to CFO. The endothelium-dependent vasorelaxation was compromised in the CFO group. Treatment with apocynin significantly reduced ROS production in the vessel wall, preserved endothelial function, and inhibited expressions of p22/p47phox and NOX2/NOX4. Although the process of CFO remodeling to restore the wall shear stress has been thought of as a physiological response, the present data implicate NADPH oxidase-produced ROS and eNOS uncoupling in endothelial dysfunction at 1 wk of CFO.

AB - Although elevation of shear stress increases production of vascular reactive oxygen species (ROS), the role of ROS in chronic flow overload (CFO) has not been well investigated. We hypothesize that CFO increases ROS production mediated in part by NADPH oxidase, which leads to endothelial dysfunction. In six swine, CFO in carotid arteries was induced by contralateral ligation for 1 wk. In an additional group, six swine received apocynin (NADPH oxidase blocker and anti-oxidant) treatment in conjunction with CFO for 1 wk. The blood flow in carotid arteries increased from 189.2 ± 25.3 ml/min (control) to 369.6 ± 61.9 ml/min (CFO), and the arterial diameter increased by 8.6%. The expressions of endothelial nitric oxide synthase (eNOS), p22/p47phox, and NOX2/NOX4 were upregulated. ROS production increased threefold in response to CFO. The endothelium-dependent vasorelaxation was compromised in the CFO group. Treatment with apocynin significantly reduced ROS production in the vessel wall, preserved endothelial function, and inhibited expressions of p22/p47phox and NOX2/NOX4. Although the process of CFO remodeling to restore the wall shear stress has been thought of as a physiological response, the present data implicate NADPH oxidase-produced ROS and eNOS uncoupling in endothelial dysfunction at 1 wk of CFO.

KW - Chronic flow overload

KW - Endothelial dysfunction

KW - NADPH oxidase

KW - Reactive oxygen species

UR - http://www.scopus.com/inward/record.url?scp=79851476020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79851476020&partnerID=8YFLogxK

U2 - 10.1152/japplphysiol.00786.2009

DO - 10.1152/japplphysiol.00786.2009

M3 - Article

VL - 110

SP - 520

EP - 527

JO - Journal of Applied Physiology

JF - Journal of Applied Physiology

SN - 8750-7587

IS - 2

ER -